Editorials1 March 1967Treatment of Chloroquine-resistant Plasmodium falciparum Infections in VietnamTHOMAS W. SHEEHY, RICHARD C. REBATHOMAS W. SHEEHYSearch for more papers by this author, RICHARD C. REBASearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-66-3-616 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSince Moore And Lanier's (1) report of two patients with chloroquine-resistantPlasmodium falciparuminfections acquired in the Magdalena Valley of Columbia in 1961, a fear has existed among malariologists that large-scale outbreaks of resistant malignant tertian malaria might develop. This fear was increased considerably by the discovery of strains of chloroquine-resistantP. falciparumin four countries of Southeast Asia between 1961 and 1963, and it was realized in the autumn of 1965 when the U. S. Army began extensive field operations in Southeast Asia. Shortly after combat units began probing the remote forested areas of the Ia-Drang and Vinh-Thanh Valleys...References1. MOORELANIER DVJE: Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Amer. J. Trop. Med. 10: 5, 1961. CrossrefMedlineGoogle Scholar2. DEGOWINPOWELL RLRD: Drug resistance of a strain of Plasmodium falciparum from Malaya. Amer. J. Trop. Med. 14: 519, 1965. CrossrefGoogle Scholar3. YOUNGCONTACOSSTITCHERMILLAR MDPGJEJW: Drug resistance in Plasmodium falciparum from Thailand. Amer. J. Trop. Med. 12: 305, 1963. CrossrefMedlineGoogle Scholar4. LEGTERSWALLACEPOWELLPOLLACK LJDKRDS: Apparent refractoriness to chloroquine, pyrimethamine, and quinine in strains of Plasmodium falciparum from Vietnam. Milit. Med. 130: 168, 1965. CrossrefMedlineGoogle Scholar5. HURLY MG: Potentiation of pyrimethamine by sulfadiazine in human malaria. Trans. Roy. Soc. Trop. Med. Hyg. 53: 412, 1959. CrossrefMedlineGoogle Scholar6. MCGREGORWILLIAMSGOODWIN IAKLG: Pyrimethamine and sulphadiazine in treatment of malaria. Brit. Med. J. 2: 728, 1963. CrossrefMedlineGoogle Scholar7. BASUMONDALCHAKRABARTI PCMMSC: Treatment of human malaria by diamino-diphenyl-sulphone (DDS), singly and in combination with pyrimethamine. A preliminary study of their effects in P. vivax and P. falciparum infections in Rajasthan, India. Indian J. Malar. 16: 157, 1962. Google Scholar8. Resistance of malaria parasites to drugs. WHO Techn. Rep. Ser. 296: 29, 1965. Google Scholar9. TARABINISECRETO GE: II, Didestrosio draminodifenilsolfone nella cura della malaria. Boll. Soc. Medicochir. Modena 1: 19, 1945. Google Scholar10. COGGESHALLMAIERBEST LTJCA: The effectiveness of two new types of chemotherapeutic agents in malaria. JAMA 117: 1077, 1941. CrossrefGoogle Scholar11. SHEEHYREBANEFFGAINTER TWRCTAJR: Supplemental sulfone (DDS) therapy for treatment of chloroquine resistant falciparum malaria. Arch. Intern. Med. (Chicago). In press. Google Scholar12. LAING AB: Antimalarial effect of sulphorthodimethoxinc (Fanasil). Brit. Med. J. 2: 1439, 1964. CrossrefMedlineGoogle Scholar13. LAING AB: Treatment of acute Falciparum malaria with sulphorthodimethoxine (Fanasil). Brit. Med. J. 1: 905, 1965. CrossrefMedlineGoogle Scholar14. BARTELLONISHEEHYTIGERTT PJTWWD: Combined therapy for chloroquineresistant Plasmodium falciparum infection: concurrent use of long-acting sulformethoxine and pyrimethamine. JAMA 199: 173, 1967. CrossrefMedlineGoogle Scholar15. KAUFMANGEISLER HEPH: The hematologic toxicity of pyrimethamine (daraprim) in man. Arch. Ophthal. (Chicago) 64: 140, 1960. CrossrefMedlineGoogle Scholar16. GARRETTCORCUS ASMG: Dapsone treatment of leprosy. Leprosy Rev. 23: 106, 1952. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByMicrotubules as antifungal and antiparasitic drug targetsRapid synthesis of sulfone derivatives as potential anti-infectious agentsEffects of folic and folinic acids on the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic cultureAdvances in chemotherapy of malariaDrug-resistant malaria—changing patterns mean difficult decisionsHaematological Aspects of MalariaA SURVEY OF IMPORTED MALARIA IN WESTERN AUSTRALIA INCLUDING FOUR CASES OF DRUG RESISTANCE*Quinine and chloroquine antagonism in falciparum malariaMalariaSulphadoxine and pyrimethamine as treatment for acute Plasmodium falciparum malaria6 Recent Advances in the Chemotherapy of MalariaThe Combined Action of Pyrimidines and Sulfonamides or Sulfones in the Chemotherapy of Malaria and Other Protozoal InfectionsMalaria: Host-Defense Mechanisms and ComplicationsFRANKLIN A. NEVA, M.D., JOHN N. SHEAGREN, M.D., N. RAPHAEL SHULMAN, M.D., CRAIG J. CANFIELDUNUSUAL HOST-PARASITE RELATIONSHIP IN BLOOD-DONORS RESPONSIBLE FOR TRANSFUSION-INDUCED FALCIPARUM MALARIAMechanism of Pyrimethamine-Induced Megaloblastosis in Human Bone MarrowRecent advances in malariologyDrug resistance in malaria—A perspectiveCHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM MALARIA IN THE UNITED KINGDOMThe narcotic addict as a medical patientMalaria in Vietnam VeteransPotential Medical Problems in Personnel Returning from VietnamDAVID N. GILBERT, WILLIAM L. MOORE JR., CHARLES L. HEDBERG, JAY P. SANFORD, M.D., F.A.C.P.Chapter 13a. Human Antiparasitic AgentsMalaria — Recent Progress and ProblemsAcquired decrease in sensitivity to quinine observed during studies with a strain of chloroquine-resistant Plasmodium falciparumClinical experience with sulphadiazine and pyrimethamine in the treatment of persons experimentally infected with chloroquine-resistant Plasmodium falciparumMalarial TransfusionsMARCEL E. CONRAD 1 March 1967Volume 66, Issue 3Page: 616-622KeywordsFearMalariaPlasmodium falciparum Issue Published: 1 March 1967 PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Sheehy et al. (1967) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: